Comparative effectiveness of second generation long-acting injectable antipsychotics based on nationwide database research in Hungary
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative effectiveness of second generation long-acting injectable antipsychotics based on nationwide database research in Hungary
Authors
Keywords
Antipsychotics, Drug therapy, Schizophrenia, Hungary, Randomized controlled trials, Health insurance, Death rates, Hospitals
Journal
PLoS One
Volume 14, Issue 6, Pages e0218071
Publisher
Public Library of Science (PLoS)
Online
2019-06-14
DOI
10.1371/journal.pone.0218071
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Changes in attitude towards LAI antipsychotic maintenance treatment: A two-year follow-up study
- (2018) Francesco Pietrini et al. EUROPEAN PSYCHIATRY
- Long-acting injectable second-generation antipsychotics in first-episode psychosis
- (2018) Monika Salgueiro et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Comparative Efficacy and Safety of Long-acting Injectable and Oral Second-generation Antipsychotics for the Treatment of Schizophrenia: A Systematic Review and Meta-analysis
- (2018) Seon-Cheol Park et al. Clinical Psychopharmacology and Neuroscience
- Mortality and the relationship of somatic comorbidities to mortality in schizophrenia. A nationwide matched-cohort study
- (2017) I. Bitter et al. EUROPEAN PSYCHIATRY
- Comparative Effectiveness of Antipsychotic Drugs for Rehospitalization in Schizophrenia—A Nationwide Study With 20-Year Follow-up
- (2017) Heidi Taipale et al. SCHIZOPHRENIA BULLETIN
- Treatment continuation of four long-acting antipsychotic medications in the Netherlands and Belgium: A retrospective database study
- (2017) Flore Decuypere et al. PLoS One
- Rates and predictors of relapse following discontinuation of antipsychotic medication after a first episode of psychosis
- (2017) Meghan Bowtell et al. SCHIZOPHRENIA RESEARCH
- LAI versus oral: A case-control study on subjective experience of antipsychotic maintenance treatment
- (2016) F. Pietrini et al. EUROPEAN PSYCHIATRY
- Comparison of Olanzapine Long-Acting Injection and Oral Olanzapine
- (2014) Holland C. Detke et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Comparative Effectiveness of Risperidone Long-Acting Injectable vs First-Generation Antipsychotic Long-Acting Injectables in Schizophrenia: Results From a Nationwide, Retrospective Inception Cohort Study
- (2014) J. Nielsen et al. SCHIZOPHRENIA BULLETIN
- Comparative effectiveness of depot and oral second generation antipsychotic drugs in schizophrenia: A nationwide study in Hungary
- (2013) István Bitter et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Long-Acting Injectable vs Oral Antipsychotics for Relapse Prevention in Schizophrenia: A Meta-Analysis of Randomized Trials
- (2012) T. Kishimoto et al. SCHIZOPHRENIA BULLETIN
- A Nationwide Cohort Study of Oral and Depot Antipsychotics After First Hospitalization for Schizophrenia
- (2011) Jari Tiihonen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study
- (2010) Istvan Bitter et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now